The expression levels of proteins related to the cGAS-STING1 pathway and AIM2 pathway were found to be higher in LV-D HCC cells compared to LV-veh HCC cells following sorafenib treatment (Figure 5D, E). The gene discussed is AIM2; the disease is hepatocellular carcinoma.